Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Annals of Pharmacotherapy|June 26, 1998
Selective serotonin-reuptake inhibitor-induced movement disordersP E Gerber, L D LyndThe Annals of Pharmacotherapy|February 26, 1998
Sumatriptan contraindications and the serotonin syndromeD M Gardner, L D LyndClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 12, 2010
Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients--a pharmacoeconomic analysisKerry Wilbur, L D Lynd, M SadatsafaviPharmacotherapy|July 1, 1996
Drug and poison information resources on the Internet, Part 1: An introductionC A Marra, L D Lynd, R McKerrow, et al.Rheumatology (Oxford, England)|August 5, 2004
The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environmentC A Marra, L D Lynd, J M Esdaile, et al.Drug Development and Industrial Pharmacy|June 16, 2010
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and SudanSheila J Thornton, Kishor M Wasan, Anna Piecuch, et al.European Journal of Clinical Nutrition|August 14, 2014
Household food insecurity and dietary diversity as correlates of maternal and child undernutrition in rural CambodiaC M McDonald, J McLean, H Kroeun, et al.Respiratory Research|May 21, 2020
Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort studyAjn Raymakers, D D Sin, M Sadatsafavi, et al.Pediatric Neurology|March 29, 2000
Factors associated with behavioral and cognitive abnormalities in children receiving topiramateP E Gerber, L Hamiwka, M B Connolly, et al.Pharmacotherapy|September 1, 1996
Drug and poison information resources on the Internet, Part 2: Identification and evaluationC A Marra, B C Carleton, L D Lynd, et al.Pageof 2